A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

Novo Nordisk A/S300 enrolled

Overview

The purpose of this survey is to collect information for scientific research and to better understand the role of systemic inflammation in identification, treatment and management of patients with Atherosclerotic Cardiovascular Disease (ASCVD) and Chronic Kidney Disease (CKD)

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)Systemic Inflammation

Interventions

No treatment givenOTHER

No treatment given

Medical Language ↔ Plain English

Inclusion Criteria: * Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). * Male or female, age above or equal to 18 years at the time of signing informed consent. * Is a Nephrologist. * Has been in practice greater than or equal to 3 years. * Sees at least 20 patients with ASCVD and CKD per month. * Treats patients for more than only dialysis Exclusion Criteria: * Previous participation in this study. Participation is defined as having given informed consent in this study * Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation * Does not meet inclusion criteria requirements

Outcomes

Primary Outcomes

Nephrologists' perceptions towards the role of systemic inflammation in the identification, treatment and management of patients with ASCVD and CKD

Multi-select from a defined list; Numerical; A 7-point Likert scale for measurement of agreement from 1 "strongly disagree" to 7 "strongly agree".

Time frame: At the time of survey response (Day 1)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.